HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong · Delayed Price · Currency is HKD 3.060
-0.140 (-4.38%)
Aug 27, 2026, 3:50 PM HKT
HighTide Therapeutics Market Cap
HighTide Therapeutics has a market cap or net worth of 1.75 billion as of August 27, 2026. Its market cap has decreased by -9.44% in one year.
Market Cap
1.75B
Enterprise Value
1.40B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.06
ChartMarket Cap Chart
Since December 22, 2023, HighTide Therapeutics's market cap has decreased from 6.37B to 1.75B, a decrease of -72.48%. That is a compound annual growth rate of -38.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 1.75B | 4.07% |
| Dec 31, 2025 | 1.69B | 157.80% |
| Dec 31, 2024 | 653.76M | -90.20% |
| Dec 29, 2023 | 6.67B | 4.68% |
| Dec 22, 2023 | 6.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Laekna | 2.61B |
| TYK Medicines | 2.48B |
| Frontage Holdings | 2.46B |
| PegBio | 2.46B |
| Shandong Boan Biotechnology | 2.43B |
| AIM Vaccine | 1.94B |
| Guangzhou Innogen Pharmaceutical Group | 1.84B |
| Mabpharm | 1.77B |